Bachem Holding AG
BANB | SW
Overview
Corporate Details
- ISIN(s):
- CH1176493729
- LEI:
- 506700S81111XI7TG884
- Country:
- Switzerland
- Address:
- Hauptstrasse 144, 4416 Bubendorf
- Website:
- https://www.bachem.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Bachem is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. The company, which has over 50 years of experience and expertise, provides products for research, clinical development and commercial application to pharmaceutical and biotechnology companies worldwide and offers a comprehensive range of services. Bachem operates internationally with headquarters in Switzerland and locations in Europe, the US and Asia. The company is listed on the SIX Swiss Exchange.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-24 02:00 |
Earnings Release
Bachem shows strong growth in the first half of 2025
|
English | 10.8 KB | |
| 2025-07-24 02:00 |
Earnings Release
Bachem mit starkem Wachstum im ersten Halbjahr 2025
|
German | 12.1 KB | |
| 2025-06-03 02:00 |
Regulatory News Service
Bachem mourns the loss of company founder Dr. h.c. Peter Grogg
|
English | 4.7 KB | |
| 2025-06-03 02:00 |
Board/Management Information
Bachem trauert um Firmengründer Dr. h.c. Peter Grogg
|
German | 7.7 KB | |
| 2025-02-27 01:00 |
Earnings Release
Bachem increases sales and profitability
|
English | 9.7 KB | |
| 2025-02-27 01:00 |
Earnings Release
Bachem erhöht Umsatz und Profitabilität
|
German | 11.3 KB | |
| 2024-07-25 02:00 |
Report Publication Announcement
Bachem with slight sales growth in the first half of 2024. Outlook confirmed fo…
|
English | 7.9 KB | |
| 2024-07-25 02:00 |
Report Publication Announcement
Bachem mit leichtem Umsatzplus im ersten Halbjahr 2024. Ausblick für das Gesam…
|
German | 8.5 KB | |
| 2024-05-28 02:00 |
Legal Proceedings Report
Incident on construction site of Bachem in Bubendorf
|
English | 2.9 KB | |
| 2024-05-28 02:00 |
Legal Proceedings Report
Vorfall auf Baustelle der Bachem in Bubendorf
|
German | 3.1 KB | |
| 2024-04-24 02:00 |
Post-Annual General Meeting Information
Bachem Annual General Meeting 2024
|
English | 3.8 KB | |
| 2024-04-24 02:00 |
Post-Annual General Meeting Information
Bachem - Ordentliche Generalversammlung 2024
|
German | 4.1 KB | |
| 2024-03-07 01:00 |
Earnings Release
Bachem continues to grow and increases dividend
|
English | 9.7 KB | |
| 2024-03-07 01:00 |
Earnings Release
Bachem wächst weiter und erhöht die Dividende
|
German | 10.7 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-05-06 | N/A | Non-Executive member | Buy | None | 30,315.25 CHF |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
AB Science | France | AB | |
|
Acticor Biotech | France | ALACT | |
|
Active Biotech | Sweden | ACTI | |
|
AcuCort AB | Sweden | ACUC |